Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eng Huat Tan

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Cancer|July 11, 2008
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinomaSwan Swan Leong, Joseph Wee, Sandeep Rajan, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Lancet (London, England)|November 1, 2005
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)Nick Thatcher, Alex Chang, Purvish Parikh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomasChee-Keong Toh, Baidah Ahmad, Richie Soong, et al.
Cancer Letters|December 23, 2016
Metronomic chemotherapy: A relook at its basis and rationaleTanujaa Rajasekaran, Quan-Sing Ng, Daniel Shao-Weng Tan, et al.
Plos One|November 21, 2019
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC)Pei Yuan Fong, Sze Huey Tan, Darren Wan Teck Lim, et al.
Plos One|May 3, 2016
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different SchedulesNatalia Sutiman, Zhenxian Zhang, Eng Huat Tan, et al.
Annals of the Academy of Medicine, Singapore|October 13, 2017
Improved Survival of Advanced Lung Cancer in Singapore Over the Past DecadeChee Keong Toh, Whee Sze Ong, Daniel Sw Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Cancer|July 11, 2008
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinomaSwan Swan Leong, Joseph Wee, Sandeep Rajan, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Lancet (London, England)|November 1, 2005
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)Nick Thatcher, Alex Chang, Purvish Parikh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomasChee-Keong Toh, Baidah Ahmad, Richie Soong, et al.
Cancer Letters|December 23, 2016
Metronomic chemotherapy: A relook at its basis and rationaleTanujaa Rajasekaran, Quan-Sing Ng, Daniel Shao-Weng Tan, et al.
Plos One|November 21, 2019
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC)Pei Yuan Fong, Sze Huey Tan, Darren Wan Teck Lim, et al.
Plos One|May 3, 2016
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different SchedulesNatalia Sutiman, Zhenxian Zhang, Eng Huat Tan, et al.
Annals of the Academy of Medicine, Singapore|October 13, 2017
Improved Survival of Advanced Lung Cancer in Singapore Over the Past DecadeChee Keong Toh, Whee Sze Ong, Daniel Sw Tan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL studyAlex Chang, Purvish Parikh, Sumitra Thongprasert, et al.
Pageof 11